METHOD AND KIT FOR PREDICTING OR MONITORING THE RESPONSE OF A CANCER PATIENT TO CHEMOTHERAPY, BASED ON MEASURING THE EXPRESSION LEVEL OF TMEM45A GENE. - Patent 2872645

(19)

(11)

EP 2 872 645 A1

(12)

(43)	Date of publication:
	20.05.2015 Bulletin 2015/21

(21)	Application number: 13727840.4

(22)	Date of filing: 31.05.2013

(51)

International Patent Classification (IPC):

C12Q 1/68^(2006.01)

(86)	International application number:
	PCT/EP2013/061286

(87)	International publication number:
	WO 2014/009055 (16.01.2014 Gazette 2014/03)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME

(30)

Priority:

12.07.2012 EP 12176145
22.02.2013 WO PCT/EP2013/053588

(71)	Applicant: Université de Namur
	5000 Namur (BE)

(72)	Inventors:
	MICHIELS, Carine B-5190 Spy (BE) FLAMANT, Lionel B-5340 Gesves (BE)

(74)	Representative: Pronovem
	Office Van Malderen Avenue Josse Goffin 158 1082 Bruxelles 1082 Bruxelles (BE)

(54)	METHOD AND KIT FOR PREDICTING OR MONITORING THE RESPONSE OF A CANCER PATIENT TO CHEMOTHERAPY, BASED ON MEASURING THE EXPRESSION LEVEL OF TMEM45A GENE.